No headlines found.
No press releases found.
No news found.
The SPDR Portfolio Emerging Markets ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Emerging BMI Index (the "Index"). The S&P Emerging BMI Index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in emerging markets. The Index component securities are a subset, based on region, of component securities included in the S&P Global BMI (Broad Market Index) ("Global Equity Index"). The Global Equity Index is a comprehensive, float-weighted, rules-based benchmark that is readily divisible and customizable. The Index is "float-adjusted," meaning that only those shares publicly available to investors are included in the Index calculation.
State Street SPDR Portfolio Emerging Markets ETF trades on the ARCA stock market under the symbol SPEM.
As of April 21, 2026, SPEM stock price declined to $50.53 with 960,827 million shares trading.
SPEM has a beta of 0.89, meaning it tends to be less sensitive to market movements. SPEM has a correlation of 0.59 to the broad based SPY ETF.
SPEM has a market cap of $17.32 billion. This is considered a Large Cap stock.
In the last 3 years, SPEM traded as high as $51.75 and as low as $32.06.
SPEM has outperformed the market in the last year with a price return of +37.3% while the SPY ETF gained +35.2%. SPEM has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.6% and +7.7%, respectively, while the SPY returned +4.2% and +6.9%, respectively.
SPEM support price is $50.40 and resistance is $51.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPEM shares will trade within this expected range on the day.
